Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1: A Randomized Trial

BACKGROUND: Limited data compare once-daily options for initial therapy for HIV-1. OBJECTIVE: To compare time to virologic failure; first grade-3 or -4 sign, symptom, or laboratory abnormality (safety); and change or discontinuation of regimen (tolerability) for atazanavir plus ritonavir with efavir...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Daar, Eric S., Tierney, Camlin, Fischl, Margaret A., Sax, Paul E., Mollan, Katie, Budhathoki, Chakra, Godfrey, Catherine, Jahed, Nasreen C., Myers, Laurie, Katzenstein, David, Farajallah, Awny, Rooney, James F., Pappa, Keith A., Woodward, William C., Patterson, Kristine, Bolivar, Hector, Benson, Constance A., Collier, Ann C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430716/
https://ncbi.nlm.nih.gov/pubmed/21320923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1059/0003-4819-154-7-201104050-00316
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi